Asan Medical Center Myocardial Infarction Registry

Recruiting

• Conditions: Myocardial Infarction, Acute; Coronary Stenosis

• Registration Number: NCT03412435
• Lead Sponsor: Seung-Jung Park

Brief Summary

This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea.

Detailed Description

This study will collect 3000 cases retrospectively and 2000 cases prospectively.

Study Timeline

• Study First Submitted: 2018-01-21
• Study First Submitted QC: 2018-01-21
• Study First Posted: 2018-01-26
• Study Start: 2018-04-27
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-23
• Last Update Posted: 2024-12-27
• Primary Completion: 2025-12-31
• Study Completion: 2030-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• All consecutive acute myocardial infarction patients diagnosed through coronary angiography

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization	1 year

Secondary Outcome Measures

Name	Time	Method
Stroke	5 year	A stroke or cerebrovascular accident with loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms at least 24 hours after onset or leading to death.
Stent thrombosis	5 year	according to Academic Research Consortium (ARC) criteria
A composite event of cardiac death and myocardial infarction	5 year
Repeat revascularization	5 year
A composite event of all-cause death and myocardial infarction	5 year
Cardiac death	5 year
Myocardial infarction	5 year
Surgery success	7 days	Successful surgery defines as no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.
All cause death	5 year
Procedure success	7 days	Successful percutaneous coronary intervention at the intended target lesion with final instant residual stenosis of less than 30% by quantitative coronary angiography (QCA) and no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.

Trial Locations

Locations (1)

Asan Medical Center; 🇰🇷 Seoul, Korea, Republic of